Swedencare Executive Insights

As part of Swedencare’s Executive Insights, John Kane, CEO of Vetio, shares his perspective on innovation, growth, and the strategic priorities shaping Vetio’s global CDMO business. John has been part of Vetio since 2015 and brings over 28 years of experience in executive roles across the Specialty Chemicals, Human Nutrition, and Animal Health industries.

We are focused on expanding our capabilities as a leading global animal health Contract Development and Manufacturing Organization (CDMO) to help our customers bring innovative products to market more efficiently. In the US, we are building out a 100,000 square foot addition for our OTC and Rx topical products, while also adding new production capacity for injection molded treats.

Pet owners are increasingly focused on preventive care, nutrition, and wellness, expecting the same level of quality as they do for themselves. This is driving demand for science-backed solutions that support long-term health, which plays to Vetio’s strength in innovation. This is a global trend, and Vetio has four sites around the world to serve its customers – United States, Canada, Ireland, and the UK.

The animal health industry is evolving rapidly, and success will depend on the ability to develop products efficiently, navigate regulatory requirements, and scale manufacturing reliably. Strong partnerships across the value chain—from product development through commercialization—will also be increasingly important as companies work to bring new solutions to market.

My main priority is building a global organization that can continue to grow while maintaining the quality, agility, and customer focus that defines Vetio. That means investing in our people, strengthening our CDMO capabilities, and creating an environment where innovation thrives.

Vetio Animal Health is a Contract Development and Manufacturing Organization (CDMO) dedicated to Animal Health, specializing in veterinary pharmaceuticals, nutritional supplements, palatants, and topical liquids. With manufacturing sites in the US, Canada, UK, and Ireland, Vetio is committed to the development and manufacturing of products that improve the lives of animals all around the world. Vetio is a wholly-owned subsidiary of Swedencare AB.